Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-08-22

Clinical Trial Update: Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the efficacy and tolerability of flunarizine versus haloperidol in schizophrenia, reporting on comparative effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flunarizine (flunarizine)
  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Ambulatório de Bipolaridade | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED